News | July 28, 2023
Biocon Foundation releases 2nd edition of consensus guidelines for head & neck cancer
Marks the World Head & Neck Cancer Day at the OCTF Conference
Marks the World Head & Neck Cancer Day at the OCTF Conference
Mage Biologics to develop a monoclonal antibody targeting ulcerative colitis
Pfizer will make upfront and milestone payments, as well as pay royalties on sales of resulting therapeutics
The agreement extends the customer's suite of cloud DevOps, data engineering, and data platform management solutions
Deal includes DTx-1252, a potential therapy for the neuromuscular disorder Charcot-Marie-Tooth disease type 1A (CMT1A), and two additional preclinical programs for other neuroscience indications
Long COVID is a debilitating chronic condition that has affected over 100 million people globally
Approval to dramatically change CAR-T therapies landscape
Marketing Authorization replaces conditional Marketing Authorization and is first for Novavax in the EU
PrecisionLife to analyse OXEGENE data to improve mechanistic understanding of endometriosis and identify novel drug targets to support the development of new personalised treatments
The positive safety review from the DSMB enables the trial to move forward as planned, with an estimated completion date in December 2023
Subscribe To Our Newsletter & Stay Updated
